problems of the digestive system: nausea, vomiting, diarrhea, stomatitis, anorexia, increased levels of uric acid in the blood. From the nervous system: headache, dizziness, visual impairment (double vision, decreased visual acuity), anxiety, depression, insomnia. Allergic reactions, including anaphylactic shock, are also possible.
Adriblastin (doxorubicin) is an antitumor antibiotic that is used to treat a variety of cancers, including breast, lung, bladder, thyroid, ovarian, osteogenic sarcoma, soft tissue sarcoma, Ewing's sarcoma, neuroblastoma, and Wilms' tumor. It is also used to treat acute lymphoblastic and myeloblastic leukemia, malignant Hodgkin's and non-Hodgkin's lymphoma.
Adriblastin is produced in Italy by the companies Carlo Erba Farmitalia and Torrent Pharmaceuticals in the form of a lyophilized powder for the preparation of an injection solution in a dosage of 10 mg. It contains doxorubicin as an active ingredient.
Despite the effectiveness of the drug, it has a number of contraindications and restrictions for use. Adriblastin cannot be used in case of hypersensitivity to hydroxybenzoates, as well as in cases of severe suppression of bone marrow function due to taking other chemotherapeutic drugs or radiation therapy. It is also contraindicated in previous treatment with anthracyclines in maximum total doses, leukopenia, thrombocytopenia, anemia, severe liver and kidney dysfunction, acute hepatitis, bilirubinemia, severe heart disease, gastric and duodenal ulcers, bleeding, tuberculosis, cystitis (with intravesical administration ), pregnancy and breastfeeding.
Side effects may occur when using adriblastine, including cardiovascular and blood disorders, nausea, vomiting, diarrhea, headache, dizziness, visual disturbances, allergic reactions and others. If any side effects occur, you should consult a doctor immediately.
Overall, adriblastine is an important drug for the treatment of cancer and other malignancies, but its use should be carefully considered by the physician, taking into account contraindications and side effects. Patients receiving adriblastine should undergo regular medical examinations and tests to monitor the effectiveness of the treatment and possible side effects. In addition, it is important to follow all doctor's orders and not change the dosage or treatment regimen without his consent.